Can colorectal cancer patients with thymidylate synthase-overexpressing liver metastases have an overall survival advantage with hepatic arterial infusion alone?
- PMID: 12972537
- DOI: 10.1200/JCO.2003.99.075
Can colorectal cancer patients with thymidylate synthase-overexpressing liver metastases have an overall survival advantage with hepatic arterial infusion alone?
Comment on
-
Thymidylate synthase expression in hepatic tumors is a predictor of survival and progression in patients with resectable metastatic colorectal cancer.J Clin Oncol. 2003 Feb 1;21(3):406-12. doi: 10.1200/JCO.2003.06.060. J Clin Oncol. 2003. PMID: 12560427 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical